Evidence map›Paper›PMID 30737289›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Tumor-suppressive signaling in the uterus.

Qinglei Li

Abstract readComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Reply to Liu et al.: ALK5-mediated tumor suppressor signaling through SMAD2 and SMAD3 in the uterus.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.Advances in experimental medicine and biology · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Qinglei LiDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843 qli@cvm.tamu.edu.ORCID 0000-0002-4515-7963

Funding

TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTIONR01HD087236 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI LI, QINGLEI · 2017 to 2021
$1.5M
TGF-BETA Signaling in Myometrial Development and FunctionR21HD073756 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI LI, QINGLEI · 2012 to 2013
$396k
Characterization of a novel mouse model with enhanced TGF-Beta signaling in the ovaryR03HD082416 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI LI, QINGLEI · 2015 to 2016
$141k
NICHD NIH HHS R01 HD087236NICHD NIH HHS R03 HD082416NICHD NIH HHS R21 HD073756
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ActivinsEndometrial NeoplasmsAnimalsFemaleHumansMiceSignal TransductionUterusActivins

Identifiers

PMID30737289
PMCPMC6397540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.